Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: Result of a self-assessment patient survey conducted by the European Heart Rhythm Association

Europace

Volumn 18, Issue 3, 2016, Pages 463-467

  Hernández Madrid, Antonio ^a   Potpara, Tatjana S ^b,c   Dagres, Nikolaos ^d   Chen, Jian ^e,f   Larsen, Torben B ^g   Estner, Heidi ^h   Todd, Derick ⁱ   Bongiorni, Maria G ^j   Sciaraffia, Elena ^k   Proclemer, Alessandro ^l   Cheggour, Saida ^m   Amara, Walid ⁿ   Blomstrom Lundqvist, Carina ^k  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ Manchester Heart Centre   (United Kingdom)

^j UNIVERSITY HOSPITAL OF PISA   (Italy)

^k UPPSALA UNIVERSITY   (Sweden)

^l SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^m CH d'Avigno   (France)

ⁿ Groupe Hospitalier Intercommunal Le Raincy Montfermeil   (France)

more..

Author keywords

Anticoagulation; Atrial fibrillation; EHRA survey; Non Vitamin K oral anticoagulants; Patient awareness; Stroke; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; VITAMIN K GROUP;

AGED; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; ATTITUDE; AWARENESS; BLEEDING; EDUCATIONAL STATUS; EUROPE; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SELF EVALUATION; TREATMENT INDICATION; ANTAGONISTS AND INHIBITORS; ATTITUDE TO HEALTH; BLOOD; BLOOD CLOTTING; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; DRUG MONITORING; HEALTH CARE SURVEY; MEDICATION COMPLIANCE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT; PATIENT EDUCATION; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; DRUG MONITORING; EDUCATIONAL STATUS; EUROPE; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENTS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME; VITAMIN K;

EID: 84965101125     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv448     Document Type: Review

References (16)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly. the Framingham Study. Arch Intern Med 1987;147:1561-4.
3. Amara W, Larsen T, Sciaraffia E, Hernández-Madrid A, Chen J, Estner H et al. Patients' attitude and knowledge about oral anticoagulation therapy: results of a selfassessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association. Europace 2016;18:151-5.
4. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace 2012;14:1385-413.
5. Själander S, Själander A, Svensson PJ, Friberg L. Atrial fibrillation patients do not benefit from acetylslicylic acid. Europace 2014;16:631-8.
6. Heidbuchel H, Verhamme P, Alings M, Antz M, HackeW, Oldgren J et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013;15:625-51.
7. Rauch U. Gender differences in anticoagulation and antithrombotic therapy. Handb Exp Pharmacol 2012;214:523-42.
8. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost 2009;101:938-42.
9. Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events-European Registry in Atrial Fibrillation (PREFER in AF). Europace 2014;16:6-14.
10. Le Heuzey JY, Ammentorp B, Darius H, De Caterina R, Schilling RJ, Schmitt J et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost 2014;111: 833-41.
11. Lahaye S, Regpala S, Lacombe S, Sharma M, Gibbens S, Ball D et al. Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost 2014;111:465-73.
12. Lane DA, Barker RV, Lip GY. Best practice for atrial fibrillation patient education. Curr Pharm Des 2014;21:533-43.
13. Potpara TS, Pison L, Larsen TB, Estner H, Madrid A, Blomström-Lundquist C et al. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey. Europace 2015;17:468-72.
14. Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: A report from the EORP-AF General Pilot Registry. Europace 2015;17:1777-86.
15. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002;87:1081-6.
16. Lane DA, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan GA, Hills MT et al. Cardiac tachyarrhythmias and patient values and preferences for their management: The European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologia (SOLEACE). Europace 2015;17:1747-69.